Supplementary Figures and Table Legends
Suppl. Figure 1 Co-immunoprecipitation of endogenous 4E-T, UNR and unrip proteins. A. Endogenous 4E-T co-precipitates with UNR and and unrip. HEK293 cell lysates were incubated with anti-4E-T antibodies (goat and rabbit) and Protein G Sepharose. Bound proteins were analysed along with input lysate and control beads only by western blotting, using indicated antibodies. B.
Endogenous UNR co-precipitates 4E-T. HEK293 cell lysates were supplemented with RNAse A as in Fig. 1 and incubated with anti-UNR antibodies and Protein A Dynabeads. Bound proteins were analysed along with input lysate and control beads only by western blotting, using indicated antibodies.
Suppl. Figure 2
GFP-4E-T interacts with CNOT4. HEK293 cells were transfected with GFP, GFP-4E-T, GFP4Emut (4E-T mutated in its eIF4E-binding site; (1) ) and GFP-4E-T1-694, and lysates were submitted to GFP-Trap immunoprecipitation. Input and bound samples were separated by a denaturing gradient gel, and analysed by western blotting with indicated antibodies. M is a molecular weight protein standard. 
Suppl. Figure 3

Suppl. Figure 5 P-body analysis using EDC3 as a P-body marker
A duplicate sample of cells presented in Figure 8A was analyzed by immunofluorescence using EDC3, 4E-T or FLAG antibodies. Cells were first transfected with no siRNA (upper panels) or with siRNA targeting 4E-T (lower panels), and 24 hours later with no plasmid DNA (control) or FLAG-4E-T plasmid DNA as indicated. Bar, 10 µm.
Suppl. Figure 6
Complementation assay with various FLAG-4E-T mutants A. Cells were successively transfected with no siRNA (upper panels) or siRNA targeting 4E-T 3'UTR (lower panels), and 24 hours later with different FLAG-4E-T plasmid DNA as indicated.
After 64 h, cells were analyzed by immunofluorescence using DDX6, 4E-T or FLAG antibodies.
Bar, 10 µm. B. Western blot analysis of transgene expression. Protein extracts from cells transfected with FLAG-tagged plasmids were analyzed by Western blotting with indicated antibodies.
Suppl. Figure 7
A. Schematic cartoon of the human EIFENIF1/4E-T gene exons 5-8, and skipping of exon 6 and 7 in human 4E-T variant 2. Not to scale. B. The expression of wild-type and exon 6/7 skipped transcripts of EIF4ENIF across a panel of human tissues. Expression levels are given relative to the endogenous controls B2M, GAPDH and GUSB, and are normalised to the median levels of full length EIFENIF1 transcripts in all tissue types. Expression of the full-length mRNA varies considerably, with highest levels seen in brain, and the extent of skipping varies across tissues too. According to Uniprot, the skipped 4E-T variant two is conserved in primates and rodents. Error bars represent the range of expression as calculated from the standard deviation of measurement.
Suppl. Table 1 Full list of 4E-T-interacting proteins. Shown are data from two separate mass spectrometry experiments, each with a FLAG-4E-T protein and FLAG-only control. The results, ranked by peptide number in experiment 1, were filtered as follows -any proteins with just one peptide in both experiments were discarded, as were proteins with peptides in control samples only, and the proteins with a significant number of peptides (approx >30%) in control samples including heat shock proteins, ribosomal proteins, tubulin, actin etc. Exceptionally, the data for PABPC1 and PABPC4 was retained, in view of the possible connection with UNR (see Discussion).
Definitions: PP av -Protein probability score; Unique peptide sequences (ignoring modified ones) for all proteins of the gene; EMPAI Calc Exponentially Modified Protein Abundance Index -calculated by ProteinCenter. 
